Predictive Oncology rises on collaboration to advance gene therapy

Axe Compute

30/03/2023 15:07

** Shares of med-tech co Predictive Oncology Inc  POAI.O 
rise 5.7% to $0.30
    ** POAI partners with biotech firm Integra Therapeutics to
advance gene therapy
    ** Says collaboration focused on pursuing a novel method to
enhance Integra Therapeutics' ability to use gene editing for
future cancer therapies
    ** Including session gains, stock down ~7% YTD

 (Reporting by Sriparna Roy)
 ((Sriparna.Roy@thomsonreuters.com;))